Premier Pharmacy Labs Inc is recalling 39 vials of Buprenorphine HCL Injection Preserved, a prescription medication used in veterinary medicine. An FDA inspection revealed that the manufacturing facility had insufficient environmental controls, potential cross-contamination issues, and lacked specific process validations needed to guarantee the product is sterile. Because these vials are intended for injection, any lack of sterility can lead to serious or life-threatening infections in animals. This recall affects all lots that are currently within their expiration dates.
Injecting a product that is not sterile can introduce bacteria or other contaminants directly into an animal's bloodstream or tissue, potentially causing severe systemic infections or localized abscesses. While no specific injuries have been reported, the manufacturing defects found by the FDA mean the safety of these injections cannot be guaranteed.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response